Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Tyrosine Phosphorylation of Sprouty Proteins Regulates Their Ability to Inhibit Growth Factor Signaling: A Dual Feedback Loop
Jacqueline M. Mason *,
Debra J. Morrison *,
Bhramdeo Bassit *,
Manjari Dimri,
Hamid Band,
Jonathan D. Licht *, and
Isabelle Gross *
* Division of Hematology/Oncology, Department of Medicine, Mount Sinai School of Medicine, New York, New York 10029 Evanston Northwestern Healthcare Research Institute, Evanston, Illinois 60201
Received for publication July 18, 2003.
Revision received December 22, 2003.
Accepted for publication January 26, 2004.
Monitoring Editor: Richard Assoian
Abstract:
Sprouty proteins are recently identified receptor tyrosine kinase(RTK) inhibitors potentially involved in many developmentalprocesses. Here, we report that Sprouty proteins become tyrosinephosphorylated after growth factor treatment. We identifiedTyr55 as a key residue for Sprouty2 phosphorylation and showedthat phosphorylation was required for Sprouty2 to inhibit RTKsignaling, because a mutant Sprouty2 lacking Tyr55 augmentedsignaling. We found that tyrosine phosphorylation of Sprouty2affected neither its subcellular localization nor its interactionwith Grb2, FRS2/SNT, or other Sprouty proteins. In contrast,Sprouty2 tyrosine phosphorylation was necessary for its bindingto the Src homology 2-like domain of c-Cbl after fibroblastgrowth factor (FGF) stimulation. To determine whether c-Cblwas required for Sprouty2-dependent cellular events, Sprouty2was introduced into c-Cbl-wild-type and -null fibroblasts. Sprouty2efficiently inhibited FGF-induced phosphorylation of extracellularsignal-regulated kinase 1/2 in c-Cbl-null fibroblasts, thusindicating that the FGF-dependent binding of c-Cbl to Sprouty2was dispensable for its inhibitory activity. However, c-Cblmediates polyubiquitylation/proteasomal degradation of Sprouty2in response to FGF. Last, using Src-family pharmacological inhibitorsand dominant-negative Src, we showed that a Src-like kinasewas required for tyrosine phosphorylation of Sprouty2 by growthfactors. Thus, these data highlight a novel negative and positiveregulatory loop that allows for the controlled, homeostaticinhibition of RTK signaling.
The Ras-GTPase activity of neurofibromin restrains ERK-dependent FGFR signaling during endochondral bone formation.
K. Ono, M. R. Karolak, J. d. l. C. Ndong, W. Wang, X. Yang, and F. Elefteriou (2013)
Hum. Mol. Genet.
|Abstract »|Full Text »|PDF »
Spry1 as a novel regulator of erythropoiesis, EPO/EPOR target, and suppressor of JAK2.
P. Sathyanarayana, A. Dev, A. Pradeep, M. Ufkin, J. D. Licht, and D. M. Wojchowski (2012)
Blood
119, 5522-5531
|Abstract »|Full Text »|PDF »
G Protein-regulated Inducer of Neurite Outgrowth (GRIN) Modulates Sprouty Protein Repression of Mitogen-activated Protein Kinase (MAPK) Activation by Growth Factor Stimulation.
T. A. Hwangpo, J. D. Jordan, P. K. Premsrirut, G. Jayamaran, J. D. Licht, R. Iyengar, and S. R. Neves (2012)
J. Biol. Chem.
287, 13674-13685
|Abstract »|Full Text »|PDF »
Regulation of Cellular Levels of Sprouty2 Protein by Prolyl Hydroxylase Domain and von Hippel-Lindau Proteins.
K. Anderson, K. A. Nordquist, X. Gao, K. C. Hicks, B. Zhai, S. P. Gygi, and T. B. Patel (2011)
J. Biol. Chem.
286, 42027-42036
|Abstract »|Full Text »|PDF »
G. N. Medina, L. S. Ehrlich, M. H. Chen, M. B. Khan, M. D. Powell, and C. A. Carter (2011)
J. Virol.
85, 7353-7362
|Abstract »|Full Text »|PDF »
Sprouty2 downregulates angiogenesis during mouse skin wound healing.
M. S. Wietecha, L. Chen, M. J. Ranzer, K. Anderson, C. Ying, T. B. Patel, and L. A. DiPietro (2011)
Am J Physiol Heart Circ Physiol
300, H459-H467
|Abstract »|Full Text »|PDF »
Sprouty Proteins Inhibit Receptor-mediated Activation of Phosphatidylinositol-specific Phospholipase C.
S. Akbulut, A. L. Reddi, P. Aggarwal, C. Ambardekar, B. Canciani, M. K. H. Kim, L. Hix, T. Vilimas, J. Mason, M. A. Basson, et al. (2010)
Mol. Biol. Cell
21, 3487-3496
|Abstract »|Full Text »|PDF »
Sprouty-4 Inhibits Transformed Cell Growth, Migration and Invasion, and Epithelial-Mesenchymal Transition, and Is Regulated by Wnt7A through PPAR{gamma} in Non-Small Cell Lung Cancer.
M. A. Tennis, M. M. Van Scoyk, S. V. Freeman, K. M. Vandervest, R. A. Nemenoff, and R. A. Winn (2010)
Mol. Cancer Res.
8, 833-843
|Abstract »|Full Text »|PDF »
HECT Domain-containing E3 Ubiquitin Ligase Nedd4 Interacts with and Ubiquitinates Sprouty2.
Cbl Controls EGFR Fate by Regulating Early Endosome Fusion.
G. D. Visser Smit, T. L. Place, S. L. Cole, K. A. Clausen, S. Vemuganti, G. Zhang, J. G. Koland, and N. L. Lill (2009)
Science Signaling
2, ra86
|Abstract »|Full Text »|PDF »
Intermolecular Interactions of Sprouty Proteins and Their Implications in Development and Disease.
F. Edwin, K. Anderson, C. Ying, and T. B. Patel (2009)
Mol. Pharmacol.
76, 679-691
|Abstract »|Full Text »|PDF »
Cell Density-Dependent Inhibition of Epidermal Growth Factor Receptor Signaling by p38{alpha} Mitogen-Activated Protein Kinase via Sprouty2 Downregulation.
A. Swat, I. Dolado, J. M. Rojas, and A. R. Nebreda (2009)
Mol. Cell. Biol.
29, 3332-3343
|Abstract »|Full Text »|PDF »
Sprouty2-Mediated Inhibition of Fibroblast Growth Factor Signaling Is Modulated by the Protein Kinase DYRK1A.
S. Aranda, M. Alvarez, S. Turro, A. Laguna, and S. de la Luna (2008)
Mol. Cell. Biol.
28, 5899-5911
|Abstract »|Full Text »|PDF »
Modulation of Endocrine Pancreas Development but not {beta}-Cell Carcinogenesis by Sprouty4.
F. Jaggi, M. A. Cabrita, A.-K. T. Perl, and G. Christofori (2008)
Mol. Cancer Res.
6, 468-482
|Abstract »|Full Text »|PDF »
A Novel Role of Sprouty 2 in Regulating Cellular Apoptosis.
Evidence That Sprouty 2 Is Necessary for Sarcoma Formation by H-Ras Oncogene-transformed Human Fibroblasts.
P. Lito, B. D. Mets, S. Kleff, S. O'Reilly, V. M. Maher, and J. J. McCormick (2008)
J. Biol. Chem.
283, 2002-2009
|Abstract »|Full Text »|PDF »
Tesk1 Interacts with Spry2 to Abrogate Its Inhibition of ERK Phosphorylation Downstream of Receptor Tyrosine Kinase Signaling.
S. Chandramouli, C. Y. Yu, P. Yusoff, D.-H. Lao, H. F. Leong, K. Mizuno, and G. R. Guy (2008)
J. Biol. Chem.
283, 1679-1691
|Abstract »|Full Text »|PDF »
Down-Regulation of Sprouty2 in Non-Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms.
H. Sutterluty, C.-E. Mayer, U. Setinek, J. Attems, S. Ovtcharov, M. Mikula, W. Mikulits, M. Micksche, and W. Berger (2007)
Mol. Cancer Res.
5, 509-520
|Abstract »|Full Text »|PDF »
Direct Binding of PP2A to Sprouty2 and Phosphorylation Changes Are a Prerequisite for ERK Inhibition Downstream of Fibroblast Growth Factor Receptor Stimulation.
D.-H. Lao, P. Yusoff, S. Chandramouli, R. J. Philp, C. W. Fong, R. A. Jackson, T. Y. Saw, C. Y. Yu, and G. R. Guy (2007)
J. Biol. Chem.
282, 9117-9126
|Abstract »|Full Text »|PDF »
The VASP-Spred-Sprouty Domain Puzzle.
K. Bundschu, U. Walter, and K. Schuh (2006)
J. Biol. Chem.
281, 36477-36481
|Abstract »|Full Text »|PDF »
A Src Homology 3-binding Sequence on the C Terminus of Sprouty2 Is Necessary for Inhibition of the Ras/ERK Pathway Downstream of Fibroblast Growth Factor Receptor Stimulation.
D.-H. Lao, S. Chandramouli, P. Yusoff, C. W. Fong, T. Y. Saw, L. P. Tai, C. Y. Yu, H. F. Leong, and G. R. Guy (2006)
J. Biol. Chem.
281, 29993-30000
|Abstract »|Full Text »|PDF »
A Functional Interaction between Sprouty Proteins and Caveolin-1.
M. A. Cabrita, F. Jaggi, S. P. Widjaja, and G. Christofori (2006)
J. Biol. Chem.
281, 29201-2912
|Abstract »|Full Text »|PDF »
Sprouty2 Is Involved in Male Sex Organogenesis by Controlling Fibroblast Growth Factor 9-Induced Mesonephric Cell Migration to the Developing Testis.
L. Chi, P. Itaranta, S. Zhang, and S. Vainio (2006)
Endocrinology
147, 3777-3788
|Abstract »|Full Text »|PDF »
Dual Effects of Sprouty1 on TCR Signaling Depending on the Differentiation State of the T Cell.
H. Choi, S.-Y. Cho, R. H. Schwartz, and K. Choi (2006)
J. Immunol.
176, 6034-6045
|Abstract »|Full Text »|PDF »
Sprouty proteins are in vivo targets of Corkscrew/SHP-2 tyrosine phosphatases.
L. A. Jarvis, S. J. Toering, M. A. Simon, M. A. Krasnow, and R. K. Smith-Bolton (2006)
Development
133, 1133-1142
|Abstract »|Full Text »|PDF »
Regulation of Sprouty Stability by Mnk1-Dependent Phosphorylation.
J. DaSilva, L. Xu, H. J. Kim, W. T. Miller, and D. Bar-Sagi (2006)
Mol. Cell. Biol.
26, 1898-1907
|Abstract »|Full Text »|PDF »
Sprouty-2 Overexpression in C2C12 Cells Confers Myogenic Differentiation Properties in the Presence of FGF2.
C. de Alvaro, N. Martinez, J. M. Rojas, and M. Lorenzo (2005)
Mol. Biol. Cell
16, 4454-4461
|Abstract »|Full Text »|PDF »
Phosphorylation of Carboxyl-terminal Tyrosines Modulates the Specificity of Sprouty-2 Inhibition of Different Signaling Pathways.
C. Rubin, Y. Zwang, N. Vaisman, D. Ron, and Y. Yarden (2005)
J. Biol. Chem.
280, 9735-9744
|Abstract »|Full Text »|PDF »
FRS2-dependent SRC activation is required for fibroblast growth factor receptor-induced phosphorylation of Sprouty and suppression of ERK activity.
X. Li, V. G. Brunton, H. R. Burgar, L. M. Wheldon, and J. K. Heath (2004)
J. Cell Sci.
117, 6007-6017
|Abstract »|Full Text »|PDF »
Regulatory Mechanisms and Function of ERK MAP Kinases.
S. Torii, K. Nakayama, T. Yamamoto, and E. Nishida (2004)
J. Biochem.
136, 557-561
|Abstract »|Full Text »|PDF »
The Expression of Sprouty1, an Inhibitor of Fibroblast Growth Factor Signal Transduction, Is Decreased in Human Prostate Cancer.
B. Kwabi-Addo, J. Wang, H. Erdem, A. Vaid, P. Castro, G. Ayala, and M. Ittmann (2004)
Cancer Res.
64, 4728-4735
|Abstract »|Full Text »|PDF »